From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Validation of the San Francisco Syncope Rule

The rule looks promising for identifying patients at risk for serious outcomes.

The causes of syncope range from potentially fatal to inconsequential. As a result, many patients are hospitalized for observation and work-up who might safely have been discharged home with follow-up. Admitted patients rarely have any work-up beyond 24 hours of cardiac monitoring and simple blood testing. These authors previously derived a syncope risk-stratification tool, dubbed the San Francisco Syncope Rule, and in this study they sought to prospectively validate it.

The rule categorizes patients as at high risk for serious outcomes if they have a history of congestive heart failure, hematocrit <30%, electrocardiogram abnormality, shortness of breath, or systolic blood pressure <90 mm Hg (the criteria can be remembered by the mnemonic, CHESS). Serious outcomes were defined broadly as death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrhage or anemia requiring transfusion, a procedural intervention to treat a related cause of syncope or any condition causing or likely to cause a return emergency department visit, and hospitalization for a related event.

The authors applied the rule to 791 ED patients who presented with syncope, defined as any transient loss of consciousness not due to trauma, intoxication, or seizure. Patients were followed up at 30 days. Overall, 411 patients (52%) were categorized as high risk. At follow-up, 53 patients (6.7%) had serious outcomes that were not clinically apparent at ED presentation. The rule was 98% sensitive and 56% specific for predicting these events.

Comment: Syncope often presents a conundrum, as patients often look remarkably well after the syncopal episode, yet discharging a patient who has a significant cause of syncope may have dire consequences. The San Francisco Syncope Rule might make discharge decisions easier, but before we can adopt it, larger, multicenter studies are needed.

— Richard D. Zane, MD, FAAEM

Published in Journal Watch Emergency Medicine July 21, 2006

Citation(s):

Quinn J et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med 2006 May; 47:448-54.

Miller CD and Hoekstra JW. Prospective validation of the San Francisco Syncope Rule: Will it change practice? Ann Emerg Med 2006 May; 47:455-6.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.